Analysis of eGFR index category and annual eGFR slope association with adverse clinical outcomes using real-world Japanese data: a retrospective database study

• Ling Zhang,
• Moe H Kyaw,
• Keizo Kanasaki,
• Sibylle Hauske,
• Yasuhisa Ono,
• Dominik Steubl,
• Yusuke Naito

Affiliations

Ling Zhang

Real World Evidence Analytics Center of Excellence, Boehringer Ingelheim Corp USA, Ridgefield, Connecticut, USA

Moe H Kyaw

Real World Evidence Analytics Center of Excellence, Boehringer Ingelheim Corp USA, Ridgefield, Connecticut, USA

Keizo Kanasaki

Department of Internal Medicine 1, Faculty of Medicine, Shimane University, Shimane, Japan

Sibylle Hauske

Therapeutic Area CardioMetabolism Respiratory Medicine, Boehringer Ingelheim International GmbH, Ingelheim, Rheinland-Pfalz, Germany

Yasuhisa Ono

Clinical Development and Medical Affairs, Nippon Boehringer Ingelheim, Tokyo, Japan

Dominik Steubl

Therapeutic Area CardioMetabolism Respiratory Medicine, Boehringer Ingelheim International GmbH, Ingelheim, Rheinland-Pfalz, Germany

Yusuke Naito

Medicine Division, Nippon Boehringer Ingelheim, Tokyo, Japan